Market View

The U.S. market is in a Confirmed Uptrend. One of only two distribution days on the S&P 500 and Nasdaq wi expire at the close Monday. Leading ideas across all sectors continue to act well with multiple names hitting ne highs, breaking out of new bases, or bouncing off support levels. We remain positive on the general market. Stocks on our U.S. Focus List—Current Sentiment Our USFL of 69 ideas (two net weekly additions) gained 1.8% on average this week, outperforming the S&P 500 (1.2%) and the Nasdaq (1.5%).

By Sector

The rally continues to broaden with multiple sectors hitting new highs over the past week. Strength across the USFL came primarily from Software-related companies. ADSK, ALRM, NOW, PAYC, RHT, RNG, SSNC, and TTWO all hit fresh highs, while LOGM, RP, TYL, and WDAY all regained their respective 50-DMAs. Financials also led with ESNT, FRC, MS, PYPL, and SCHW all hitting new highs.

Global Health Care Sector

Offers the world’s leading institutional investment managers a distinct blend of quantitative, fundamental, and technical expertise in global stock buy-and-sell recommendations. Its core method profiles stocks displaying the characteristics of out performance proven persistent over market history—drawn from the firm’s industry leading database.
William O’Neil + Co., Incorporated is a Registered Investment Advisor with the State of California and certain other states. The firm and its affiliates may now or in the future have positions in the securities mentioned in this or other publications. Charts are intended to be used as tools to assist institutional investors in identifying equity ideas worthy for further review. Charts provide certain current and historical information, but are not a substitute for comprehensive analysis of the individual stocks. For further information about our business and legal policies, please see williamoneil.com/legal.

Market View

The U.S. market remains in an Uptrend Under Pressure. Next week, three distribution days will expire on the Nasdaq and two on the S&P 500. We are still looking for a heavy volume break into new highs before upgrading the market status. Conversely, if the market trades lower, we view the 100-DMA as a key level of support. Stocks on our U.S. Focus List—Current Sentiment Our USFL of 63 ideas lost 0.8% on average this week, underperforming the S&P 500 (-0.6%) but outperforming the Nasdaq (-1.2%).

By Sector Health Care led all sectors this week breaking into YTD highs. ABMD and RGEN both found support just below their respective 50-DMAs and are now both actionable. Among our five biotech ideas, ALXN, CELG, and VRTX remain actionable at or near new highs. New addition, ILMN, continues to trend higher after breaking above $200 late last week. Technology ideas also continue to act well with multiple USFL ideas reaching new highs this week. WB, ADBE, TTWO, MCHP, NOW, CRM, RHT, ATVI, and WDAY all hit fresh highs. Conversely, Financials came under heavy pressure. WAL and MKTX were removed from the USFL due to technical deterioration, while FRC and SCHW are now both trading below their respective 200-DMAs.

Market View

The U.S. market remains in an Uptrend Under Pressure. Distribution on the Nasdaq remains elevated at seven days. The index still has an A/D Rating of E and price continues to hit resistance around its 50-DMA and a newly formed downward trending channel line. Additionally, the U.S. Focus List count has fallen from 68 to 60 names over the past three weeks, with ~30% of the current list trading below their 50-DMAs. Going forward, we will be looking for distribution to subside and for price/volume action to improve on both the major averages and lead-ership ideas alike. We maintain our cautious stance on the general market.

Stocks on our U.S. Focus List—Current Sentiment
Our USFL of 60 ideas gained 0.7% on average this week, in-line with the S&P 500 (0.7%) and the Nasdaq (0.8%).

By Sector
Multiple Technology ideas on the U.S. Focus List continue to act well. QTWO, WB, PAYC, NOW, RHT, CRM, TTWO, ALRM, and ADBE are all trading at or near new highs. MDSO and VEEV are the two outliers, each under pressure following Q2 earnings results from VEEV. Health Care ideas also improved, though all ideas remain in consolidation. VRTX continues to consolidate constructively above its 50-DMA. Conversely, our lone Basic Mate-rial name, USCR, broke its 50-DMA in heavy volume on the back of weakness across the Cement group. The stock is now sitting just above its 200-DMA.